Respy
Tiotropium Bromide 18MCG
Use of ingredients from FDA approved sources to ensure safety
(HP Operating Procedures)
Healthcare Professionals login
Respy
Tiotropium Bromide 18MCG
Significant delay in disease progression with the use of Tiotropium in early-stage COPD
(New England Journal of Medicine)
View Research Library
Respy
Tiotropium Bromide 18MCG
Greater than 50% improvement in exercise tolerance with Tiotropium
(The CHEST)
Watch Video
Respy
Tiotropium Bromide 18MCG
Tiotropium bromide inhalation powder capsules are compatible across all DPI devices
Each transparent capsule contains 18mcg of tiotropium bromide as monohydrate
Available in a pack of 30s transparent capsules
For inhalation only and not to be swallowed
Product Information
Indications
Maintenance bronchodilator treatment to relieve symptoms of patients with
Chronic Obstructive Pulmonary Disease (COPD)
Contraindications
Hypersensitivity to tiotropium, ipratropium or atropine
Adverse Effects
Dry mouth
Blurred Vision
Constipation
Duration of Action
Provides relief for up to 24 hours
Dosage
Inhalation of 1 capsule (18mcg) once daily with any available DPI device
Additional Information/ Precautions
Respy is not indicated as a rescue medication for the relief of acute bronchospasm in COPD
For prescribing information,
Please Click Here
Previous
Next
Zoom In
Zoom Out
100%
Page:
/ 2
Member Log In
×
Mobile Number or Email Address
Receive Link
Not Registered? Please Sign Up
PMDC Number
Full Name
Email Address
Mobile Number
(e.g. 03xxxxxxxxx)
Hospital/Clinic Name & Address
Speciality
--Select--
GP
Consultant
Surgeon
Other
How Did You Hear About Us?
--Select--
Fellow doctor
Our representative
Other
Sign Up
